Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements

Nucleic Acids Research

Volumn 40, Issue 16, 2012, Pages 7739-7752

  Al Haj, Latifa ^a   Blackshear, Perry J ^b   Khabar, Khalid S A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; MUTANT PROTEIN; RIBONUCLEASE L; TRISTETRAPROLIN;

ANIMAL CELL; ARTICLE; AU RICH ELEMENT; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; DIMERIZATION; DNA STRUCTURE; EMBRYO; ENZYME REGULATION; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HALF LIFE TIME; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; P21 CIP1 WAF1 GENE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RNA METABOLISM; RNA STABILITY; RNASEL GENE; STABLE EXPRESSION; TTP GENE;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENDORIBONUCLEASES; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICE; MICE, INBRED C57BL; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; TRISTETRAPROLIN;

EID: 84870477645     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks545     Document Type: Article

References (58)

1. Zhou, A., Paranjape, J., Brown, T.L., Nie, H., Naik, S., Dong, B., Chang, A., Trapp, B., Fairchild, R., Colmenares, C. et al. (1997) Interferon action and apoptosis are defective in mice devoid of 20, 50-oligoadenylate-dependent RNase L. EMBO J., 16, 6355-6363.
2. Khabar, K.S., Dhalla, M., Siddiqui, Y., Zhou, A., Al-Ahdal, M.N., Der, S.D., Silverman, R.H. and Williams, B.R. (2000) Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res., 20, 653-659.
3. Bisbal, C. and Silverman, R.H. (2007) Diverse functions of RNase L and implications in pathology. Biochimie, 89, 789-798.
4. Castelli, J.C., Hassel, B.A., Wood, K.A., Li, X.L., Amemiya, K., Dalakas, M.C., Torrence, P.F. and Youle, R.J. (1997) A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J. Exp. Med., 186, 967-972.
5. Al-Ahmadi, W., Al-Haj, L., Al-Mohanna, F.A., Silverman, R.H. and Khabar, K.S. (2009) RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth. Oncogene, 28, 1782-1791.
6. Zhou, A., Paranjape, J.M., Hassel, B.A., Nie, H., Shah, S., Galinski, B. and Silverman, R.H. (1998) Impact of RNase L overexpression on viral and cellular growth and death. J. Interferon Cytokine Res., 18, 953-961.
7. Bisbal, C., Silhol, M., Laubenthal, H., Kaluza, T., Carnac, G., Milligan, L., Le Roy, F. and Salehzada, T. (2000) The 20-50 oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Mol. Cell. Biol., 20, 4959-4969.
8. Andersen, J.B., Li, X.L., Judge, C.S., Zhou, A., Jha, B.K., Shelby, S., Zhou, L., Silverman, R.H. and Hassel, B.A. (2007) Role of 2-5A-dependent RNase-L in senescence and longevity. Oncogene, 26, 3081-3088.
9. Nakayama, K. (1998) Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays, 20, 1020-1029.
10. Abbas, T. and Dutta, A. (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer, 9, 400-414.
11. Jung, Y.S., Qian, Y. and Chen, X. (2010) Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal, 22, 1003-1012.
12. Kuribayashi, K. and El-Deiry, W.S. (2008) Regulation of programmed cell death by the p53 pathway. Adv. Exp. Med. Biol., 615, 201-221.
13. Lafarga, V., Cuadrado, A., Lopez de Silanes, I., Bengoechea, R., Fernandez-Capetillo, O. and Nebreda, A.R. (2009) p38 Mitogen-activated protein kinase-and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol. Cell. Biol., 29, 4341-4351.
14. Wang, W., Furneaux, H., Cheng, H., Caldwell, M.C., Hutter, D., Liu, Y., Holbrook, N. and Gorospe, M. (2000) HuR regulates p21 mRNA stabilization by UV light. Mol. Cell Biol., 20, 760-769.
15. Halees, A.S., El-Badrawi, R. and Khabar, K.S. (2008) ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse. Nucleic Acids Res., 36, D137-D140.
16. Khabar, K.S. (2010) Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol. Life Sci., 67, 2937-2955.
17. Stumpo, D.J., Lai, W.S. and Blackshear, P.J. (2010) Inflammation: cytokines and RNA-based regulation. Wiley Interdiscip. Rev. RNA, 1, 60-80.
18. Lai, W.S., Parker, J.S., Grissom, S.F., Stumpo, D.J. and Blackshear, P.J. (2006) Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol. Cell. Biol., 26, 9196-9208.
19. Al-Souhibani, N., Al-Ahmadi, W., Hesketh, J.E., Blackshear, P.J. and Khabar, K.S. (2010) The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Oncogene, 29, 4205-4215.
20. Hitti, E., Al-Yahya, S., Al-Saif, M., Mohideen, P., Mahmoud, L., Polyak, S.J. and Khabar, K.S. (2010) A versatile ribosomal protein promoter-based reporter system for selective assessment of RNA stability and post-transcriptional control. RNA, 16, 1245-1255.
21. Al-Zoghaibi, F., Ashour, T., Al-Ahmadi, W., Abulleef, H., Demirkaya, O. and Khabar, K.S. (2007) Bioinformatics and experimental derivation of an efficient hybrid 30 untranslated region and use in expression active linear DNA with minimum poly(A) region. Gene, 391, 130-139.
22. al-Haj, L., Al-Ahmadi, W., Al-Saif, M., Demirkaya, O. and Khabar, K.S. (2009) Cloning-free regulated monitoring of reporter and gene expression. BMC Mol. Biol., 10, 20.
23. Al-Ahmadi, W., Al-Ghamdi, M., Al-Haj, L., Al-Saif, M. and Khabar, K.S. (2009) Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res., 37, 3612-3624.
24. Al-Ahmadi, W., Al-Ghamdi, M., Al-Haj, L., Al-Saif, M. and Khabar, K.S.A. (2009) Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res., 37, 3612-3624.
25. Tchen, C.R., Brook, M., Saklatvala, J. and Clark, A.R. (2004) The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. J. Biol. Chem., 279, 32393-32400.
26. Brooks, S.A., Connolly, J.E. and Rigby, W.F.C. (2004) The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J. Immunol., 172, 7263-7271.
27. Lai, W.S., Kennington, E.A. and Blackshear, P.J. (2002) Interactions of CCCH zinc finger proteins with mRNA: non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs. J. Biol. Chem., 277, 9606-9613.
28. Chakrabarti, A., Jha, B.K. and Silverman, R.H. (2011) New insights into the role of RNase L in innate immunity. J. Interferon Cytokine Res., 31, 49-57.
29. Carpten, J., Nupponen, N., Isaacs, S., Sood, R., Robbins, C., Xu, J., Faruque, M., Moses, T., Ewing, C., Gillanders, E. et al. (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat. Genet., 30, 181-184.
30. Castelli, J.C., Hassel, B.A., Maran, A., Paranjape, J., Hewitt, J.A., Li, X.L., Hsu, Y.T., Silverman, R.H. and Youle, R.J. (1998) The role of 20-50 oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ., 5, 313-320.
31. Liu, W., Liang, S.L., Liu, H., Silverman, R. and Zhou, A. (2007) Tumour suppressor function of RNase L in a mouse model. Eur. J. Cancer, 43, 202-209.
32. Urisman, A., Molinaro, R.J., Fischer, N., Plummer, S.J., Casey, G., Klein, E.A., Malathi, K., Magi-Galluzzi, C., Tubbs, R.R., Ganem, D. et al. (2006) Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog., 2, e25.
33. Xiang, Y., Wang, Z., Murakami, J., Plummer, S., Klein, E.A., Carpten, J.D., Trent, J.M., Isaacs, W.B., Casey, G. and Silverman, R.H. (2003) Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 20, 50-oligoadenylates. Cancer Res., 63, 6795-6801.
34. Khabar, K.S., Siddiqui, Y.M., al-Zoghaibi, F., al-Haj, L., Dhalla, M., Zhou, A., Dong, B., Whitmore, M., Paranjape, J., Al-Ahdal, M.N. et al. (2003) RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR. J. Biol. Chem., 278, 20124-20132.
35. Li, X.L., Blackford, J.A., Judge, C.S., Liu, M., Xiao, W., Kalvakolanu, D.V. and Hassel, B.A. (2000) RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J. Biol. Chem., 275, 8880-8888.
36. Koromilas, A.E., Li, S. and Matlashewski, G. (2001) Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev., 12, 157-170.
37. Wadler, S. and Schwartz, E.L. (1990) Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res., 50, 3473-3486.
38. Miyamoto, A., Umeshita, K., Sakon, M., Nagano, H., Eguchi, H., Kishimoto, S., Dono, K., Nakamori, S., Gotoh, M. and Monden, M. (2000) Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil. J. Gastroenterol Hepatol., 15, 1447-1451.
39. Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K. et al. (2003) Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature, 424, 516-523.
40. Chelbi-Alix, M.K., Quignon, F., Pelicano, L., Koken, M.H. and de The, H. (1998) Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol., 72, 1043-1051.
41. Matsuoka, M., Tani, K. and Asano, S. (1998) Interferon-alphainduced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages. Oncogene, 16, 2075-2086.
42. Sangfelt, O., Erickson, S., Castro, J., Heiden, T., Gustafsson, A., Einhorn, S. and Grander, D. (1999) Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Oncogene, 18, 2798-2810.
43. Sangfelt, O., Erickson, S., Einhorn, S. and Grander, D. (1997) Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines. Oncogene, 14, 415-423.
44. Hobeika, A.C., Subramaniam, P.S. and Johnson, H.M. (1997) IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells. Oncogene, 14, 1165-1170.
45. Subramaniam, P.S. and Johnson, H.M. (1997) A role for the cyclindependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons. J. Interferon Cytokine Res., 17, 11-15.
46. Rysiecki, G., Gewert, D.R. and Williams, B.R. (1989) Constitutive expression of a 20, 50-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon. Res., 9, 649-657.
47. Hassel, B.A., Zhou, A., Sotomayor, C., Maran, A. and Silverman, R.H. (1993) A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J., 12, 3297-3304.
48. Wreschner, D.H., James, T.C., Silverman, R.H. and Kerr, I.M. (1981) Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A20p)nA) in interferon-treated cells. Nucleic Acids Res., 9, 1571-1581.
49. Molinaro, R.J., Jha, B.K., Malathi, K., Varambally, S., Chinnaiyan, A.M. and Silverman, R.H. (2006) Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 20, 50-oligoadenylate synthetase from prostate cancer cells. Nucleic Acids Res., 34, 6684-6695.
50. Dong, B. and Silverman, R.H. (1997) A Bipartite Model of 2-5A-dependent RNase L. J. Biol. Chem., 272, 22236-22242.
51. Lai, W.S., Carballo, E., Strum, J.R., Kennington, E.A., Phillips, R.S. and Blackshear, P.J. (1999) Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell Biol., 19, 4311-4323.
52. Lykke-Andersen, J. and Wagner, E. (2005) Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev., 19, 351-361.
53. Horner, T.J., Lai, W.S., Stumpo, D.J. and Blackshear, P.J. (2009) Stimulation of Polo-Like Kinase 3 mRNA Decay by Tristetraprolin. Mol. Cell. Biol., 29, 1999-2010.
54. Cho, S.J., Zhang, J. and Chen, X. (2010) RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability. Nucleic Acids Res., 38, 2256-2267.
55. Shu, L., Yan, W. and Chen, X. (2006) RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript. Genes Dev., 20, 2961-2972.
56. Yano, M., Okano, H.J. and Okano, H. (2005) Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation. J. Biol. Chem., 280, 12690-12699.
57. Liu, J., Shen, X., Nguyen, V.A., Kunos, G. and Gao, B. (2000) Alpha(1) adrenergic agonist induction of p21(waf1/cip1) mRNA stability in transfected HepG2 cells correlates with the increased binding of an AU-rich element binding factor. J. Biol. Chem., 275, 11846-11851.
58. Joseph, B., Orlian, M. and Furneaux, H. (1998) p21waf1 mRNA contains a conserved element in its 30-untranslated region that is bound by the Elav-like mRNA-stabilizing proteins. J. Biol. Chem., 273, 20511-20516.